Lupin’s USA facility gets 6 USFDA observations ...Middle East

Bloomberg News Today - News
Lupin’s USA facility gets 6 USFDA observations
Last Updated : May 20 2024 | 9:16 AM IST Lupin said that US Food and Drug Administration (USFDA) issued form 483 with six observations after the inspection conducted at its Somerset, New Jersey manufacturing facility. The Pre-approval inspection was conducted from 7 May 2024 to 17 May 2024, and closed with an issuance of a Form-483 with six observations. It will respond to the U.S. FDA within the stipulated timeframe. Mumbai-based Lupin is an innovation-led transnational pharmaceutical company. It develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and acro

Hence then, the article about lupin s usa facility gets 6 usfda observations was published today ( ) and is available on Bloomberg News Today ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Lupin’s USA facility gets 6 USFDA observations )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News